MENU
+Compare
KTTA
Stock ticker: NASDAQ
AS OF
Jun 26, 04:59 PM (EDT)
Price
$0.72
Change
-$0.00 (-0.00%)
Capitalization
5.39M

KTTA Pasithea Therapeutics Corp Forecast, Technical & Fundamental Analysis

Pasithea Therapeutics Corp is a biotechnology company... Show more

KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for KTTA with price predictions
Jun 25, 2025

KTTA's Stochastic Oscillator is remaining in oversold zone for 3 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Moving Average Convergence Divergence (MACD) for KTTA just turned positive on June 25, 2025. Looking at past instances where KTTA's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KTTA advanced for three days, in of 132 cases, the price rose further within the following month. The odds of a continued upward trend are .

KTTA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 02, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on KTTA as a result. In of 69 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KTTA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for KTTA entered a downward trend on June 25, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.415) is normal, around the industry mean (16.539). P/E Ratio (0.000) is within average values for comparable stocks, (59.016). KTTA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.300). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (255.605).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. KTTA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KTTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

KTTA is expected to report earnings to -17 cents per share on August 30

Pasithea Therapeutics Corp KTTA Stock Earnings Reports
Q2'23
Est.
$-0.17
Q1'23
Est.
$-0.17
Q4'22
Est.
$-0.18
Q3'22
Missed
by $0.03
Q2'22
Est.
$-0.11
The last earnings report on May 31 showed earnings per share of -17 cents, meeting the estimate of -17 cents. With 61.88K shares outstanding, the current market capitalization sits at 5.39M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1111 Lincoln Road
Phone
+1 702 514-4174
Employees
8
Web
https://www.pasithea.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KXIN0.940.04
+4.43%
Kaixin Holdings
SPWH3.28-0.03
-0.76%
Sportsman's Warehouse Holdings
MEDP311.14-4.14
-1.31%
Medpace Holdings
WNS57.45-0.89
-1.53%
WNS (Holdings) Limited
DDD1.39-0.05
-3.47%
3D Systems Corp

KTTA and Stocks

Correlation & Price change

A.I.dvisor tells us that KTTA and FATE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KTTA and FATE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KTTA
1D Price
Change %
KTTA100%
-1.03%
FATE - KTTA
32%
Poorly correlated
-0.85%
ACET - KTTA
25%
Poorly correlated
+0.58%
SCNI - KTTA
25%
Poorly correlated
+6.33%
TRAW - KTTA
24%
Poorly correlated
-8.39%
ARVN - KTTA
24%
Poorly correlated
+0.78%
More